
|Slideshows|June 21, 2019
FDA approvals you might have missed
Author(s)Miranda Hester
A look at 5 recent approvals from the US Food and Drug Administration (FDA), including treatment for systemic lupus erythematosus, a new gene therapy, and pain relief for patients with irritable bowel syndrome.
Advertisement
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA approves depemokimab for severe asthma in patients 12 years and older
2
Phase 3 trial meets primary endpoint for VIASKIN Peanut patch in children aged 4–7 years
3
19-year-old female with painful, purpuric nodules in the phalanges of her fingers
4
Special Report: Rethinking type 1 diabetes through a screening lense
5






